Partridge Foundation

Partridge Therapeutics is a Boston-based biotechnology company focused on the discovery and development of small molecule therapeutics targeting protein-protein interactions (PPIs). The company leverages a proprietary platform to identify and drug novel binding sites on proteins previously considered undruggable, with a primary focus on oncology and neurodegenerative diseases. Founded by Dr. Lee Rubin of Harvard University, the company aims to expand the reach of small molecule drugs to high-value targets that are currently inaccessible. Partridge Therapeutics is backed by prominent venture capital firms, including 5AM Ventures and AbbVie Ventures, and operates within the vibrant Cambridge-Boston biotech ecosystem.